ikonisys mario crovettoDear Madam, Dear Sir, Dear Investor, 

It is with great pleasure that I welcome you to the website dedicated to investors.

Ikonisys' innovative approach is the automated detection, analysis and interpretation of rare and very rare cells. Ikonisys deploys a combination of equipment, software and reagents for automated diagnosis to improve the reporting of test results from medical laboratories.

Ikonisys' ambition is the early and accurate detection of cancerous diseases.

We thank you for your interest in our company,

Mario Crovetto

Invalid Input
* Required fields
* Required fields
* Required fields
* Required fields
* Required fields
* Required fields
* Required fields
* Required fields
* Required fields

Invalid Input
* Required fields
* Required fields
Invalid Input
Entrée non valide
Invalid Input
Invalid Input
* Required fields
Invalid Input

Ikonisys

Alessandro Mauri

CFO

This email address is being protected from spambots. You need JavaScript enabled to view it.

NewCap

Investors Relations

Louis-Victor Delouvrier

This email address is being protected from spambots. You need JavaScript enabled to view it.